Solid Dosage
A wealth of expertise from powder to coated tablet
Offering an unrivaled range of tableting technologies, GEA’s portfolio includes powder handling, granulating, drying, compression and coating equipment for both batch and continuous manufacturing applications, as well as a variety of solutions for contained processing
Because our products are designed and built with system integration in mind, no matter which type of oral solid dosage (OSD) form you need to produce, we can help you to select the optimal solution.
By embracing digitalization, modularization, holistic product innovation and sustainability, we can supply both standard and custom-configured lines to suit specific projects. For example, fluid bed dryers and coaters can be combined with top- or bottom-drive high shear mixer/granulators, wet and dry milling facilities, product handling systems, binder and coating preparation units, filtration units and/or tablet presses. Furthermore, safety, containment, product flow and building requirements are fully incorporated for optimum process efficiency.
The Future of Pharmaceutical Production
With a stronger focus on efficiency, Industry 4.0 and the environment, the pharmaceutical industry is evolving. GEA is committed to transforming tomorrow with better processes and has enthusiastically embraced these themes. For example, when the industry embraced continuous manufacturing to improve efficiencies and product quality, GEA was already bringing process-ready technology to the market.
And when it comes to digitalization, we’ve been innovating for years and bringing new services to customers, such as our virtual reality (VR)-based training modules. Ongoing product innovation, making our equipment better for the user and the planet, ensures that when you invest in a GEA process line, you’re making the right choice.
产品与技术
显示 4 个，共 29 个
CIP/SIP 解决方案
GEA 创新的 CIP 理念可满足全方位的高标准要求。我们的专家可确保产品在每个工艺点的安全。我们的每一次升级都基于当地的情况和客户的具体要求，可为客户实现显著地成本节约。
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Pharma Solids Insight Stories
Continuous Innovation: How GEA is Leading the Future of Pharmaceutical Manufacturing
From the first ConsiGma® line in 2004 to the launch of CDC Flex today, GEA has been at the forefront of pharmaceutical innovation.
Continuous innovation is our commitment — to our customers, to the industry, and to a better world.
Pharmaceutical granulation: An established technology in a changing world
Optimizing the granulation process — the most important unit operation during the production of pharmaceutical oral solid dosage forms — is not only a critical aspect of operational excellence, it also plays a major role in preventing downstream compression problems.
